Company Filing History:
Years Active: 2018
Title: The Innovations of Ron Bonaccorso
Introduction
Ron Bonaccorso is an accomplished inventor based in Syracuse, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of peptide sequences that serve as agonists for specific receptors.
Latest Patents
Bonaccorso holds a patent for "Coagonists of glucagon-like peptide 1 receptor and neuropeptide Y2 receptor." This innovative patent includes peptide sequences that can act as agonists for both the glucagon-like peptide 1 receptor (GLP-IR) and the neuropeptide Y2 receptor (NPYR2). The sequences are designed to incorporate regions that correspond to natural substrates and known agonists, providing a unique approach to receptor activation.
Career Highlights
Ron Bonaccorso is affiliated with Syracuse University, where he continues to engage in research and development. His work has garnered attention for its potential applications in therapeutic settings, particularly in the management of metabolic disorders.
Collaborations
One of his notable collaborators is Robert Patrick Doyle, with whom he has worked on various projects related to peptide research and receptor interactions.
Conclusion
Ron Bonaccorso's innovative work in peptide sequences and receptor activation highlights his contributions to the field of biochemistry. His patent and ongoing research at Syracuse University demonstrate his commitment to advancing scientific knowledge and potential therapeutic applications.